SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001420720-24-000020
Filing Date
2024-05-13
Accepted
2024-05-13 16:14:05
Documents
113
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ibio-20240331x10q.htm   iXBRL 10-Q 2649013
2 EX-10.9 ibio-20240331xex10d9.htm EX-10.9 138468
3 EX-31.1 ibio-20240331xex31d1.htm EX-31.1 15712
4 EX-31.2 ibio-20240331xex31d2.htm EX-31.2 18737
5 EX-32.1 ibio-20240331xex32d1.htm EX-32.1 10591
6 EX-32.2 ibio-20240331xex32d2.htm EX-32.2 6707
7 GRAPHIC ibio-20240331x10q001.jpg GRAPHIC 84419
8 GRAPHIC ibio-20240331x10q002.jpg GRAPHIC 60450
9 GRAPHIC ibio-20240331x10q003.jpg GRAPHIC 70535
  Complete submission text file 0001420720-24-000020.txt   13795773

Data Files

Seq Description Document Type Size
10 EX-101.SCH ibio-20240331.xsd EX-101.SCH 128256
11 EX-101.CAL ibio-20240331_cal.xml EX-101.CAL 88507
12 EX-101.DEF ibio-20240331_def.xml EX-101.DEF 435071
13 EX-101.LAB ibio-20240331_lab.xml EX-101.LAB 760132
14 EX-101.PRE ibio-20240331_pre.xml EX-101.PRE 717893
117 EXTRACTED XBRL INSTANCE DOCUMENT ibio-20240331x10q_htm.xml XML 2274902
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35023 | Film No.: 24939217
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)